Cardiovascular and Metabolic Research Group

The Cardiovascular and Metabolic Research Group is focused on using existing human health data in combination with experimental approaches to understand the relationship between various lifestyle, clinical, molecular and genetic factors in determination of risk of cardiovascular and metabolic diseases. 

Cardiovascular diseases including myocardial infarction, arrhythmia, heart failure and stroke are considered non-communicable disease as unlike communicable diseases they are not transmittable between living creatures. Currently 85.6 million people live with one form of cardiovascular disease. 

Cardiovascular diseases including myocardial infarction, arrhythmia, heart failure and stroke kill 17 million people in the world annually.

The main risk factors for these diseases include cardio-metabolic features such as abnormal blood lipids and glucose regulation and obesity leading to diabetes and hypertension.

Tackling cardiovascular disease

• Our research into cardiovascular and metabolic diseases enlightens preventive and treatment strategies to decrease the burden of these non-communicable diseases.

Cardiovascular health experts

• With the development of the medical school, our group is home to cardiologists and researchers with relevant area of research.

Associated research centres

Inflammation Research and Translational Medicine

Driving scientific innovation and discovery for diagnosis, treatment, and management of cardiovascular disease, inflammatory and immune disorders, microbial resistance, and cancer.

Health and Wellbeing Across the Lifecourse

Inequalities in health and wellbeing in the UK and internationally; welfare, health and wellbeing; ageing studies; health economics.